Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Operating Leases (2019 - 2025)

Phibro Animal Health has reported Operating Leases over the past 7 years, most recently at $33.0 million for Q4 2025.

  • Quarterly results put Operating Leases at $33.0 million for Q4 2025, up 16.43% from a year ago — trailing twelve months through Dec 2025 was $33.0 million (up 16.43% YoY), and the annual figure for FY2025 was $33.7 million, up 12.79%.
  • Operating Leases for Q4 2025 was $33.0 million at Phibro Animal Health, roughly flat from $33.1 million in the prior quarter.
  • Over the last five years, Operating Leases for PAHC hit a ceiling of $33.7 million in Q2 2025 and a floor of $27.0 million in Q1 2021.
  • Median Operating Leases over the past 5 years was $30.0 million (2023), compared with a mean of $30.3 million.
  • Biggest five-year swings in Operating Leases: surged 65.89% in 2021 and later decreased 10.62% in 2023.
  • Phibro Animal Health's Operating Leases stood at $27.7 million in 2021, then increased by 7.49% to $29.8 million in 2022, then grew by 4.79% to $31.2 million in 2023, then decreased by 9.23% to $28.3 million in 2024, then increased by 16.43% to $33.0 million in 2025.
  • The last three reported values for Operating Leases were $33.0 million (Q4 2025), $33.1 million (Q3 2025), and $33.7 million (Q2 2025) per Business Quant data.